Reduction of lymphocyte at early stage elevates severity and death risk of COVID-19 patients: a hospital-based case-cohort study

Jun Fei, Lin Fu, Ying Li, Hui-Xian Xiang, Ying Xiang, Meng-Die Li, Fang-Fang Liu, De-Xiang Xu, Hui Zhao
doi: https://doi.org/10.1101/2020.04.02.20050955

Article usage

Article usage: April 2020 to November 2024

AbstractFullPdf
Apr 202012470490
May 20204130123
Jun 2020235060
Jul 2020147050
Aug 202082039
Sep 202060022
Oct 202071011
Nov 202067029
Dec 202064018
Jan 202159125
Feb 202171127
Mar 202163131
Apr 2021100327
May 2021109134
Jun 202181327
Jul 202186226
Aug 202197522
Sep 202166121
Oct 202175111
Nov 202156223
Dec 20214306
Jan 202257610
Feb 202243013
Mar 20223407
Apr 202240110
May 202276113
Jun 20224307
Jul 20223505
Aug 20223714
Sep 20225907
Oct 202270010
Nov 2022146112
Dec 20224814
Jan 20234523
Feb 202334110
Mar 202333010
Apr 202321119
May 202317212
Jun 20231358
Jul 2023603
Aug 202322139
Sep 20232855
Oct 20231503
Nov 20231644
Dec 20231601
Jan 20241004
Feb 2024544
Mar 20242414
Apr 20241536
May 20241003
Jun 20241049
Jul 20247016
Aug 202415314
Sep 202416430
Oct 20241348
Nov 202415320
Back to top
Posted April 06, 2020.
Download PDF
Data/Code
Email
Reduction of lymphocyte at early stage elevates severity and death risk of COVID-19 patients: a hospital-based case-cohort study
Jun Fei, Lin Fu, Ying Li, Hui-Xian Xiang, Ying Xiang, Meng-Die Li, Fang-Fang Liu, De-Xiang Xu, Hui Zhao
medRxiv 2020.04.02.20050955; doi: https://doi.org/10.1101/2020.04.02.20050955
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area